Benzinga's Top Downgrades

Analysts at Barclays downgraded athenahealth, Inc (NASDAQ: ATHN) from Equal-weight to Underweight. The price target for AthenaHealth has been lowered from $140 to $110. AthenaHealth shares closed at $162.98 on Monday.Analysts at Brean Capital downgraded Osiris Therapeutics, Inc. (NASDAQ: OSIR) from Hold to Sell. The price target for Osiris Therapeutics is set to $8. Osiris Therapeutics shares closed at $13.98 on Monday.Wedbush downgraded Polaris Industries Inc. (NYSE: PII) from Outperform to Neutral. The price target for Polaris Industries has been lowered from $156 to $117. Polaris Industries shares closed at $105.49 on Monday. RBC Capital downgraded Urban Outfitters, Inc. (NASDAQ: URBN) from Outperform to Sector Perform. The price target for Urban Outfitters has been lowered from $32 to $23. Urban Outfitters shares closed at $22.67 on Monday.Analysts at Sterne Agee CRT downgraded Five Below Inc (NASDAQ: FIVE) from Buy to Neutral. The price target for Five Below has been lowered to $30. Five Below shares closed at $28.49 on Monday.BMO Capital downgraded Kindred Biosciences Inc (NASDAQ: KIN) from Outperform to Market Perform. The price target for Kindred Biosciences has been lowered from $14 to $5. Kindred Biosciences shares closed at $4.73 on Monday.Analysts at Oppenheimer downgraded Hess Corp. (NYSE: HES) from Outperform to Perform. Hess shares closed at $61.84 on Monday.Atlantic Equities downgraded W W Grainger Inc (NYSE: GWW) from Neutral to Underweight. The price target for W W Grainger has been lowered from $220 to $183. W W Grainger shares closed at $198.28 on Monday.Analysts at KeyBanc downgraded Airgas, Inc. (NYSE: ARG) from Overweight to Sector Weight. Airgas shares closed at $106.18 on Monday.Analysts at Goldman Sachs downgraded Clovis Oncology Inc (NASDAQ: CLVS) from Buy to Neutral. The price target for Clovis Oncology has been lowered from $123 to $23. Clovis Oncology shares closed at $30.24 on Monday.